Scientists at the University of Glasgow developed a bioengineered bone marrow (BM) model that helped them to evaluate potential use of a combined CRISPR-CAR T cell therapy in the treatment of acute ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback